Blueberries Medical Corp. Announces C$1.1 Million Private Placement

Toronto-based Blueberries Medical Corp., a company dedicated to health and wellness, has announced a C$1.1 million non-brokered private placement. This transaction involves selling 84,615,385 common shares at C$0.013 per share. The expected gross proceeds of approximately US$781,000 will fund operational expansion and general corporate purposes. The closing is anticipated around August 26, 2026.

The offering is led by Terraflos Inc., controlled by Blueberries' chairman Facundo Garreton. The company will bypass formal valuation and minority shareholder approval due to specific regulatory exemptions. No additional fees or commissions will be paid for this placement.